首页 › 基金 › Soleus Capital Management, L.P. › URGN

Soleus Capital Management, L.P. 对 URGN 的持仓历史

UROGEN PHARMA LTD · 医疗保健

Soleus Capital Management, L.P. 在 Q2 2026 的 13F 申报中披露持有 URGN(UROGEN PHARMA LTD)829,810 股,市值约 US$30.5M,约占其申报组合的 1.05%,在其申报持仓中市值排名第 29 位。 Soleus Capital Management, L.P. 最近 12 个申报季度中有 7 个季度披露了 URGN 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q2 2026)829.81K 股
申报持仓市值$30.54M
组合权重1.05%
首次申报Q3 2023
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Soleus Capital Management, L.P. 对 URGN 的持仓演变

Soleus Capital Management, L.P. 于 Q3 2023 首次披露 URGN 持仓:372,000 股(约 US$5.2M)。 该持仓在 Q2 2026 达到峰值 829,810 股,市值约 US$30.5M。 在 7 次申报中,Soleus Capital Management, L.P. 2 次增持、2 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 829,810 股、市值约 US$30.5M,环比增持 102,810 股。。 持仓曾出现大幅变动:Q3 2025 减持约 69% (随后一个季度股价上涨 17%)、Q4 2025 减持约 78% (随后一个季度股价下跌 23%)、Q1 2026 增持约 385% (随后一个季度股价上涨 105%)。

逐季持仓明细

季度股数金额变化
Q3 2023 372.00K $5.21M 新进
Q1 2024 10.00K $150.00K 新进
Q2 2025 2.19M $29.93M 新进
Q3 2025 679.00K $13.55M 减持
Q4 2025 150.00K $3.51M 减持
Q1 2026 727.00K $13.07M 增持
Q2 2026 829.81K $30.54M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 URGN 与 13F 数据

URGN(UROGEN PHARMA LTD)属于医疗保健行业。我们追踪的基金中还有 39 只申报持有 URGN,申报仓位最大的包括:RTW INVESTMENTS, LP (US$167.2M), Kynam Capital Management, LP (US$89.6M), Jefferies Financial Group Inc. (US$80.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 URGN 的基金

查看 URGN 的全部基金持有人 →

常见问题

How long has Soleus Capital Management, L.P. held URGN?

Soleus Capital Management, L.P. has disclosed URGN holdings in 7 of the last 12 reported quarters, going back to Q3 2023.

What is Soleus Capital Management, L.P.'s current position in URGN?

As of Q2 2026, Soleus Capital Management, L.P. holds 829.81K shares of URGN (UROGEN PHARMA LTD), valued at $30.54M, representing 1.05% of its reported portfolio and ranking #29.

Has Soleus Capital Management, L.P. been buying or selling URGN?

In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. increased its position in URGN. The position peaked in Q2 2026 at 829.81K shares.

Which other funds hold URGN?

Other major institutional holders of URGN include RTW INVESTMENTS, LP, Kynam Capital Management, LP, Jefferies Financial Group Inc., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.